Prestige Consumer Healthcare (PBH) Interest Coverage Ratio Growth (1y) (2011 - 2025)
Prestige Consumer Healthcare (PBH) Interest Coverage Ratio Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn | -14.04% |
| 4 | Takeda Pharmaceutical | 27.53 Bn | 23.47 Bn | 4.39 Bn | -63.16% |
| 5 | United Therapeutics | 23.06 Bn | 20.91 Bn | 648.10 Mn | -58.34% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.32 Bn | 18.52 Bn | 1.16 Bn | 97.17% |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | -87.09% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -14.91% |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.38 Bn | 157.37 Mn | -47.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -47.39% |
| Sep 30, 2025 | -50.43% |
| Jun 30, 2025 | -50.44% |
| Mar 31, 2025 | -41.89% |
| Dec 31, 2024 | 12.47% |
| Sep 30, 2024 | 7.19% |
| Jun 30, 2024 | 5.47% |
| Mar 31, 2024 | -121.80% |
| Dec 31, 2023 | 21.91% |
| Sep 30, 2023 | -2.34% |
| Jun 30, 2023 | 10.80% |
| Mar 31, 2023 | 460.46% |
| Dec 31, 2022 | 18.79% |
| Sep 30, 2022 | 34.55% |
| Jun 30, 2022 | -18.91% |
| Mar 31, 2022 | -211.74% |
| Dec 31, 2021 | -13.35% |
| Sep 30, 2021 | -8.06% |
| Jun 30, 2021 | 46.72% |
| Mar 31, 2021 | 275.68% |